ALEXIS POTHURAJU: Open Payments
NPI 1902630809 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$266 in 14 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $31 · 2025 $266
Food & beverage: $266
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $55 |
| ABBVIE INC. | 3 | $51 |
| Organon LLC | 2 | $44 |
| Novo Nordisk Inc | 2 | $39 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Abbott Laboratories | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: MOUNJARO, VRAYLAR, NEXPLANON, ILUMYA, CAPLYTA, Wegovy, FREESTYLE LIBRE 3, FARXIGA.
Industry payments across NC — which companies pay providers there.
